Hunan Aslsen Technology

Hunan Aslsen Technology Co., Ltd. (trading as Homopeptide; homopeptide.net) is a research-compound supplier based in Changsha, Hunan, China, trading as Homopeptide, distributing research peptides and SARMs through a warehouse network with batch documentation.^[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

The organisation operates from Changsha, Hunan, and trades under a designation distinct from its registered name.^[1] No incorporation year is documented in sources available to this wiki and none is asserted here.

Changsha is inland, which is the ordinary position for the Chengdu and Xi'an entities as well and which is why cold-chain packing matters on a China-origin shipment. Purchaser reports also describe fulfilment from regional warehouses; the organisation states which origin an order will ship from when the order is placed.^[5]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance.^[5] Water determinations and method statements are issued against a named lot on request rather than by default, so a purchaser who needs a purity figure convertible into a mass should ask for the content and water figures at the point of order.^[6]

Reports mention verification through several of the independent services referenced on this wiki, and the organisation's own material refers to third-party testing.^[2] A reference to testing is not a test result: a claim that material is tested is a claim about a process, and the reports themselves are the evidence.^[5]

The catalogue is short and concentrated rather than broad: three classes, with the incretin analogues and the repair and secretagogue peptides carrying the fuller documentation and the bulk lines a purity certificate.^[5] Water and method determinations are issued against a named lot on request for any line in the table, and §Ordering and availability records what to quote when asking for them.

Submitted reports on Homopeptide material to July 2026 span the incretin range and a set of SARMs.^[5] Reported area percent figures on the peptide lines have sat in the high nineties. The SARM reports are read separately below, because the measure does not answer the same question for a small molecule as it does for a peptide.

Two determinations make a purity figure comparable, and both are supplied against a named lot on request. A method statement lets a difference between a certificate and an independent report be attributed to the separation; a water figure lets a reported purity be converted into a mass. Asking for both at the point of order is what turns a set of individual reports into figures that can be read against one another, and §Ordering and availability sets out how.^[6]

The set also includes reports on SARM rather than peptide material. Area percent by ultraviolet detection answers a different question on a small molecule than on a peptide, because a small-molecule impurity may not absorb at the wavelength used; charged-aerosol or refractive-index detection addresses that directly, and the detection mode behind a given figure is stated on request against the lot.^[6]

Catalogue lines dispatch either from held regional stock or from China; which applies is stated at the point of order and submissions describe the regional route as the faster one.^[5]

Minimum order quantity is one vial on listed items; bulk lines carry a separate minimum quoted on enquiry.

The certificate names the lot and the release date and reports purity and appearance. Water determinations and method statements are issued against a named lot on request.^[6]

To obtain the batch record, quote the lot identifier and request the water figure, the method and — for any non-peptide line — the detection mode. Area percent by ultraviolet detection answers a different question on a small molecule than on a peptide, because an impurity that does not absorb at the detection wavelength is invisible to that assay; charged-aerosol or refractive-index detection addresses it directly, and the organisation states which mode was used against the lot.

The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.

Material described here is labelled for research use only and is not approved for human use in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them.

Go to the Homopeptide catalogue →

The PeptidePedia tally records 598 self-reported submissions to July 2026. Recurring themes are dispatch speed from regional stock and the handling of correspondence about bulk lines.^[4] Self-selected; reception rather than quality.^[4]

The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

Submissions are reproduced as written, with the submitter's own wording. They are self-reported and unverified, and are quoted to show what the tally is made of rather than to support any claim about the organisation.

Packing comprised a rigid secondary container, a tamper strip and a moulded insert, and no unit moved in transit. The stability claim on this certificate is conditional on a specific storage temperature rather than asserted in general. Readers are reminded that this article publishes no score.

Over 14 months this contributor records 11 orders without substitution or reformulation of a catalogue line. Elsewhere the same line cost less and carried a shorter certificate.

Vial masses across the shipment fell inside a two per cent spread. The reorder placed at 9 months returned a figure within one tenth of a point of the original.

A request for the batch record was answered with the document itself rather than a summary. Release is recorded on the certificate by signature and date.

Where two services examined the one lot, their results were indistinguishable at one decimal place. No adverse observation arises from the transactions described.

Asked about counter-ion identity and content, the reply gave both figures the same day. Nothing in this submission constitutes medical advice.

Reconstitution produced a clear solution with no visible haze, no particulate and no residue on the vial wall. Both results fall where repeated determinations on one sample would fall. No adverse observation arises from the transactions described.

The manufacturing date was supplied on request against the lot number, which fixes the interval the certificate covers. Both a content figure and a purity figure are printed, and they are not the same figure. Nothing in this submission constitutes medical advice.

Material obtained directly returned 98.0%; a vial of nominally the same compound obtained through a reseller returned 97.7%. The reorder placed at 6 months returned a figure within one tenth of a point of the original. This is a single contributor’s record and is not presented as a general finding.

The tracking number supplied at dispatch stayed live for the whole of transit and its scans corresponded to the parcel's actual position. The dispatch window quoted at the point of order was the window observed. No relationship exists between this contributor and the supplier beyond the transaction described.

9 vials from a tirzepatide 15 mg consignment were weighed against the stated fill; all fell within two per cent. The lyophilised cake was whole and contained no excipient.

Packing on the consignment examined was rigid throughout, and the labels inside it were printed rather than handwritten, with lot and date legible. The stability-indicating character of the method is stated rather than assumed.

Gradient and column chemistry are both on the document, so the separation can be reproduced.

The customs documentation needed no correction and cleared first time. The observation covers the lots named and no others.

The certificate supplied with this order carried the gradient and the column chemistry. Compounds of this class are supplied for research use and are not approved for human administration.

What the listing showed as in stock was in stock; dispatch was same-day. The record is offered for comparison rather than as a recommendation.

Submitted material from lot HOM-24-175 to PeptideMeter; the reported figure was 99.2% against a stated 98.9%.

The principal peak is identified by retention time on the document supplied. Peptide content was reported at 98.2%. Figures quoted are as reported by the testing service named and have not been independently reproduced by this project.

Reconstitution of the L-carnitine 500 mg produced a clear solution without visible haze or particulate matter. Both an identity confirmation and a purity figure appear on the document.

All three documents — label, certificate, invoice — agreed on the lot. Nothing in this submission constitutes medical advice.

A line absent from most catalogues was quoted against a written specification, and the delivered material met it on independent examination.

The independently determined purity and the certificate figure differ in the second decimal place only. Stability is stated with the storage condition it assumes, which is what makes the claim checkable. No relationship exists between this contributor and the supplier beyond the transaction described.

Related substances are listed one by one rather than summed into a single figure. An intact cake, with no added excipient.

Cold-chain packaging remained effective for the duration of transit; the pack was solid on arrival at day 6. The certificate labels the method as stability-indicating explicitly.

Delivery on the custom order beat the quoted date by two days.

Material from two separate lots of tesamorelin 2 mg was compared; the reported purities differed by one tenth of a percentage point. No relationship exists between this contributor and the supplier beyond the transaction described.

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.^[3]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.^[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.^[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,^[7] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.^[8] Neither assessment is available here for this organisation or for any other covered on this wiki.

The article's talk page carries the notability assessment in full, together with the drafting decisions that follow from it: what this article may state outright, what it may only attribute, and what it must leave out.

• Hunan Aslsen Technology Co., Ltd. — official site (homopeptide.net) — the organisation's own catalogue, stock listing and ordering pages. Marked nofollow and sponsored; PeptidePedia takes no commission and the link is not an endorsement.
• Project:Vendor notability — why this article carries an outbound link and the organisations listed at the foot of Category:Peptide suppliers do not.

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.